Abdo A. Elfiky
PhD Molecular Biophysics (Computational)
Cairo University, biophysics new building
(email)
Announcements
Publications
Bio
Classes
Images
Calendar
Presentations
Curriculum Vitea
Links
Media
Drug repurposing against MERS CoV and SARS-COV-2 PLpro in silico
View
What links here
Citation:
Elfiky, A., N. Ibrahim, and W. Elshemey, Drug repurposing against MERS CoV and SARS-COV-2 PLpro in silico, , 2020.
Export
RTF
Tagged
XML
BibTex
Google Scholar
Abstract:
n/a
Notes:
n/a
Awards
Journal Review
List of Journals
Patents application
RESEARCH
WORK EXPERIENCE
Workshops and conferences
أنشطة تطوير العملية التعليمية
إشراف الرسائل العلمية
المشاريع البحثية
دورات تنمية مهارات أعضاء هيئة التدريس
Tags
Boceprevir Fluorinated sulfonamide HCV Molecular modeling Mutated NS3 protease Protein– ligand docking
(1)
COVID-19; SARS-CoV-2; New variant VUI 202012/01; computational biophysics; GRP78; Spike RBD.
(1)
GRP78Heat shock proteinsHSP70StressUnfolded protein responseMembrane receptors
(1)
HCV • molecular docking • mucormycosis • RNA-dependent RNA polymerase • Sofosbuvir
(1)
Molecular modelingMolecular dynamics simulationHCV genotype 4aPolymeraseNucleotide inhibitorsProtein-ligand docking
(1)
virology; Docking; QSAR; MERS; HCV
(1)
Recent Publications
In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids
Triple in silico targeting of IMPDH enzyme and RNA-dependent RNA polymerase of both SARS-CoV-2 and Rhizopus oryzae
Can de-phosphorylation of serine-5 in the C-terminal domain of human polymerase II affect its interaction with the PA C-terminal domain of bat Flu A polymerase?
In vivo dose measurements for tangential field-in-field ultra-hypofractionated breast radiotherapy
Tepotinib and tivantinib as potential inhibitors for the serine/threonine kinase of the mpox virus: insights from structural bioinformatics analysis
more
Tourism